Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Pfizer discloses selective hydroxamic acid-based MMP-13 inhibitors

March 19, 1999

FDA approves Prosorba Column for use in rheumatoid arthritis

March 18, 1999

Celgene describes new series for reducing TNF-alpha levels

March 18, 1999

Peripheral cannabinoid receptor ligands in development at Japan Tobacco

March 16, 1999

Roberts acquires Lodine rights in the U.K. and Ireland

March 12, 1999

Vertex initiates phase I clinical trial with VX-745

March 11, 1999

Cypress Bioscience and Fresenius sign definitive agreement for Prosorba Column

March 11, 1999

Merck Frosst presents clinical data on COX-2 inhibitor at Canadian meeting

March 10, 1999

Microbial metabolite inhibits ICAM-1/LFA-1-mediated cell adhesion

March 8, 1999

Cyclooxygenase-inhibitory indoles under study at Pfizer

March 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...